ERP Consultant for Pharmaceutical

The pharmaceutical process map in an ERP

A pharmaceutical ERP has to follow material and status at the same time. For a manufacturer, the process I map usually runs like this:

• Supply: approved supplier list -> purchase order -> receipt by lot with supplier batch and expiry -> quarantine.
• Quality: sampling -> testing in the lab or QC system -> release, rejection or retest -> status updated in the ERP.
• Production: batch order from an approved formula and version -> material issue of released lots only -> in-process records -> yield and scrap -> finished batch in quarantine.
• Release and distribution: batch release -> FEFO picking -> dispatch with batch on every delivery -> customer and batch history retained.
• After sale: returns, complaints and, if needed, recall by batch.

For a distributor or wholesaler the production step disappears, but receipt, status, expiry, storage conditions and batch-level dispatch remain central. Each arrow in this map is a control point: who may move the material, under which status, and what record proves it. That is where I spend most of the requirements effort, using ERP process mapping sessions with operations and quality together.

Common pain points in pharmaceutical operations

Pharmaceutical companies that outgrow basic systems tend to report similar problems:

• Status lives outside the system: quarantine and release are tracked on labels and logbooks, so the ERP can allow a sale or issue that quality would never approve.
• Slow traceability: answering "which customers received material from this raw material lot?" takes days of manual searching.
• Expiry write-offs: without FEFO picking and near-expiry alerts, short-dated stock is found too late to sell or use.
• Formula and version confusion: recipes are copied between spreadsheets, and the version used for a batch is not always clear.
• Disconnected quality records: deviations, change controls and test results sit in a separate tool or on paper with no link to the batch in the ERP.
• Costing gaps: rejected batches, rework and destruction are not costed consistently, so product margins look better than they are.

These problems carry business risk and compliance risk at the same time. I make sure the ERP design addresses the business side clearly while leaving regulatory interpretation to your quality and regulatory teams and their advisors. If your current ERP project is already struggling with these issues, see ERP recovery.

Recommended ERP modules and where a QMS fits

The ERP core for a pharmaceutical business usually includes:

A recurring design decision is the boundary between the ERP and a dedicated quality management system or LIMS. Deviations, CAPA, change control, training records and document control are often better served by specialized tools, linked to the ERP by batch and material references. I make that boundary explicit in the solution design so no one assumes the ERP covers what it does not.

Validation, audit trails and controlled records

When an ERP supports activities that fall under good practice regulations, validation requirements may apply to the system and to how it is configured and changed. The exact expectations depend on your products, markets, regulators and quality system, and they are for your quality function to determine. What I make sure of is that the ERP project does not make validation harder than it needs to be.

In practice that means:

• Writing user requirements that are specific and testable, each with an ID that links to configuration and test evidence.
• Checking during selection how the platform handles audit trails, user access, electronic approvals and record retention.
• Keeping customization to a minimum, because every custom component adds testing and change control effort for its whole life.
• Planning a controlled release process for configuration changes after go-live.
• Agreeing early with the implementation partner what documentation they will provide.

I do not issue compliance opinions or replace a validation specialist. I make the requirements, design and testing traceable, which is the foundation any validation approach needs. Structured testing and UAT with quality sign-off is part of every pharmaceutical engagement I support.

Data migration and integrations for pharmaceutical ERP

Migration in pharmaceuticals carries more weight than in most industries, because open stock must arrive in the new system with the correct lot, expiry and status. A single batch migrated as released when it was in quarantine is a real problem.

My migration checklist covers:

1. Material and product masters with approved specifications and units of measure.
2. Formulas and routings, with the currently approved version clearly identified.
3. Open stock by lot, expiry, status and location, reconciled to a physical count.
4. Open purchase orders, production orders and customer orders.
5. Historic batch genealogy, or a defined approach for how older traceability will be retrieved.
6. Reconciliation reports signed off by operations, quality and finance.

Typical integrations include the LIMS or QC system for test results and release, a QMS for deviations and change control, warehouse scanning for lot capture, serialization or labelling systems where required, and distributor or customer portals. Each one is specified with the data owner and error handling. Food producers face similar batch and expiry questions with different regulation; see ERP for food & beverage, and plan migration with ERP data migration support.